Detalhe da pesquisa
1.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis
; 78(2): 259-268, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740559
2.
Exploration of a Potential DOOR Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs.
Clin Infect Dis
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527855
3.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis
; 78(2): 248-258, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738153
4.
Desirability of outcome ranking for obstetrical trials: illustration and application to the ARRIVE trial.
Am J Obstet Gynecol
; 230(3): 370.e1-370.e12, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741532
5.
The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions.
Clin Infect Dis
; 77(Suppl 4): S279-S287, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843121
6.
Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S288-S294, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843120
7.
Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S314-S320, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843119
8.
The Future Ain't What It Used to Be Out With the Old In With the Better: Antibacterial Resistance Leadership Group Innovations.
Clin Infect Dis
; 77(Suppl 4): S321-S330, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843122
9.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Clin Infect Dis
; 76(3): e1157-e1165, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031403
10.
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S305-S313, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843118
11.
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
Clin Infect Dis
; 77(Suppl 4): S295-S304, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843115
12.
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
N Engl J Med
; 383(3): 207-217, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668111
13.
Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing.
J Clin Microbiol
; 61(12): e0061423, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962552
14.
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.
Clin Infect Dis
; 73(2): 344-350, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33245333
15.
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration.
Clin Infect Dis
; 73(7): 1231-1238, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978146
16.
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Stroke
; 52(11): 3482-3489, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477459
17.
Antibacterial Resistance Leadership Group 2.0: Back to Business.
Clin Infect Dis
; 73(4): 730-739, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588438
18.
Presenting Risks and Benefits: Helping the Data Monitoring Committee Do Its Job.
Ann Intern Med
; 172(2): 119-125, 2020 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31739312
19.
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
Clin Infect Dis
; 70(4): 698-703, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414121
20.
Average Weighted Accuracy: Pragmatic Analysis for a Rapid Diagnostics in Categorizing Acute Lung Infections (RADICAL) Study.
Clin Infect Dis
; 70(12): 2736-2742, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157863